• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习在预测糖皮质激素减量后巨细胞动脉炎发作中的有效性。

Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering.

机构信息

Department of Emergency and Organ Transplantation, Rheumatology Unit, University of Bari, Bari, Italy.

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

出版信息

Front Immunol. 2022 Apr 5;13:860877. doi: 10.3389/fimmu.2022.860877. eCollection 2022.

DOI:10.3389/fimmu.2022.860877
PMID:35450069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9017227/
Abstract

BACKGROUND

Inferential statistical methods failed in identifying reliable biomarkers and risk factors for relapsing giant cell arteritis (GCA) after glucocorticoids (GCs) tapering. A ML approach allows to handle complex non-linear relationships between patient attributes that are hard to model with traditional statistical methods, merging them to output a forecast or a probability for a given outcome.

OBJECTIVE

The objective of the study was to assess whether ML algorithms can predict GCA relapse after GCs tapering.

METHODS

GCA patients who underwent GCs therapy and regular follow-up visits for at least 12 months, were retrospectively analyzed and used for implementing 3 ML algorithms, namely, Logistic Regression (LR), Decision Tree (DT), and Random Forest (RF). The outcome of interest was disease relapse within 3 months during GCs tapering. After a ML variable selection method, based on a XGBoost wrapper, an attribute core set was used to train and test each algorithm using 5-fold cross-validation. The performance of each algorithm in both phases was assessed in terms of accuracy and area under receiver operating characteristic curve (AUROC).

RESULTS

The dataset consisted of 107 GCA patients (73 women, 68.2%) with mean age ( ± SD) 74.1 ( ± 8.5) years at presentation. GCA flare occurred in 40/107 patients (37.4%) within 3 months after GCs tapering. As a result of ML wrapper, the attribute core set with the least number of variables used for algorithm training included presence/absence of diabetes mellitus and concomitant polymyalgia rheumatica as well as erythrocyte sedimentation rate level at GCs baseline. RF showed the best performance, being significantly superior to other algorithms in accuracy (RF 71.4% vs LR 70.4% vs DT 62.9%). Consistently, RF precision (72.1%) was significantly greater than those of LR (62.6%) and DT (50.8%). Conversely, LR was superior to RF and DT in recall (RF 60% vs LR 62.5% vs DT 47.5%). Moreover, RF AUROC (0.76) was more significant compared to LR (0.73) and DT (0.65).

CONCLUSIONS

RF algorithm can predict GCA relapse after GCs tapering with sufficient accuracy. To date, this is one of the most accurate predictive modelings for such outcome. This ML method represents a reproducible tool, capable of supporting clinicians in GCA patient management.

摘要

背景

推断性统计方法未能识别出糖皮质激素(GCs)减量后复发性巨细胞动脉炎(GCA)的可靠生物标志物和危险因素。机器学习(ML)方法可以处理患者特征之间复杂的非线性关系,这些关系很难用传统的统计方法来建模,将这些关系合并起来可以输出预测结果或给定结果的概率。

目的

本研究旨在评估 ML 算法是否可以预测 GCs 减量后 GCA 的复发。

方法

回顾性分析了接受 GCs 治疗并至少随访 12 个月的 GCA 患者,并将其用于实施 3 种 ML 算法,即逻辑回归(LR)、决策树(DT)和随机森林(RF)。感兴趣的结局是 GCs 减量期间 3 个月内疾病复发。在基于 XGBoost 包装器的 ML 变量选择方法之后,使用 5 折交叉验证,使用属性核心集来训练和测试每个算法。在两个阶段中,根据准确性和接收器操作特征曲线(AUROC)下面积来评估每个算法的性能。

结果

该数据集包含 107 例 GCA 患者(73 例女性,68.2%),发病时的平均年龄( ± 标准差)为 74.1( ± 8.5)岁。GCs 减量后 3 个月内,40/107 例(37.4%)患者出现 GCA 发作。由于 ML 包装器,用于算法训练的变量数量最少的属性核心集包括是否存在糖尿病和伴发性肌痛性风湿症以及 GCs 基线时的红细胞沉降率水平。RF 显示出最佳性能,在准确性方面明显优于其他算法(RF 71.4% vs LR 70.4% vs DT 62.9%)。一致地,RF 精度(72.1%)明显大于 LR(62.6%)和 DT(50.8%)。相反,LR 在召回率方面优于 RF 和 DT(RF 60% vs LR 62.5% vs DT 47.5%)。此外,RF AUROC(0.76)明显优于 LR(0.73)和 DT(0.65)。

结论

RF 算法可以以足够的准确性预测 GCs 减量后 GCA 的复发。到目前为止,这是针对该结果的最准确预测模型之一。这种 ML 方法是一种可重复的工具,能够支持临床医生对 GCA 患者的管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604f/9017227/8712a5f30b96/fimmu-13-860877-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604f/9017227/781ee1191bf1/fimmu-13-860877-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604f/9017227/f9964c6ed6ad/fimmu-13-860877-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604f/9017227/c6857e4dfcbf/fimmu-13-860877-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604f/9017227/8712a5f30b96/fimmu-13-860877-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604f/9017227/781ee1191bf1/fimmu-13-860877-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604f/9017227/f9964c6ed6ad/fimmu-13-860877-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604f/9017227/c6857e4dfcbf/fimmu-13-860877-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/604f/9017227/8712a5f30b96/fimmu-13-860877-g004.jpg

相似文献

1
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering.机器学习在预测糖皮质激素减量后巨细胞动脉炎发作中的有效性。
Front Immunol. 2022 Apr 5;13:860877. doi: 10.3389/fimmu.2022.860877. eCollection 2022.
2
Prediction and feature selection of low birth weight using machine learning algorithms.利用机器学习算法预测和选择低出生体重。
J Health Popul Nutr. 2024 Oct 12;43(1):157. doi: 10.1186/s41043-024-00647-8.
3
Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.患有巨细胞动脉炎或多发性肌痛症或两种疾病的患者的长期糖皮质激素治疗:来自国家风湿病学数据库的结果。
Rheumatol Int. 2018 Apr;38(4):569-577. doi: 10.1007/s00296-017-3874-3. Epub 2017 Nov 9.
4
Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.巨细胞动脉炎与风湿性多肌痛:系统评价。
JAMA. 2016 Jun 14;315(22):2442-58. doi: 10.1001/jama.2016.5444.
5
Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry.在一项多中心回顾性土耳其登记研究中,巨细胞动脉炎患者的复发率较低。
Clin Exp Rheumatol. 2024 Apr;42(4):816-821. doi: 10.55563/clinexprheumatol/zr7s0g. Epub 2023 Nov 15.
6
Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.基层医疗中的血管炎:风湿性多肌痛和巨细胞动脉炎。
Prim Care. 2018 Jun;45(2):305-323. doi: 10.1016/j.pop.2018.02.007.
7
Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica.风湿性多肌痛中巨细胞动脉炎的危险因素及预测模型
Am J Med. 1997 Apr;102(4):331-6. doi: 10.1016/s0002-9343(97)00117-4.
8
Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions.巨细胞动脉炎患者治疗结局不良的相关因素:大血管病变的临床意义。
Arthritis Res Ther. 2020 Apr 7;22(1):72. doi: 10.1186/s13075-020-02171-6.
9
Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.巨细胞动脉炎患者的疾病复发:一项前瞻性纵向队列研究。
J Rheumatol. 2015 Jul;42(7):1213-7. doi: 10.3899/jrheum.141347. Epub 2015 Apr 15.
10
Predictors for treatment success and expression of glucocorticoid receptor in giant cell arteritis and polymyalgia rheumatica.巨细胞动脉炎和风湿性多肌痛的治疗成功预测因子和糖皮质激素受体的表达。
J Rheumatol. 2009 Oct;36(10):2269-76. doi: 10.3899/jrheum.090075. Epub 2009 Aug 14.

引用本文的文献

1
Machine Learning for Predicting Recurrent Course in Uveitis Using Baseline Clinical Characteristics.利用基线临床特征的机器学习预测葡萄膜炎的复发病程
Invest Ophthalmol Vis Sci. 2025 Aug 1;66(11):67. doi: 10.1167/iovs.66.11.67.
2
Applications of Artificial Intelligence in Vasculitides: A Systematic Review.人工智能在血管炎中的应用:一项系统综述。
ACR Open Rheumatol. 2025 Mar;7(3):e70016. doi: 10.1002/acr2.70016.
3
The Future of Giant Cell Arteritis Diagnosis and Management: A Systematic Review of Artificial Intelligence and Predictive Analytics.

本文引用的文献

1
Artificial Intelligence in Dermatopathology: New Insights and Perspectives.皮肤病理学中的人工智能:新见解与展望
Dermatopathology (Basel). 2021 Sep 1;8(3):418-425. doi: 10.3390/dermatopathology8030044.
2
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents.基于机器学习的生物制剂治疗类风湿关节炎患者持续缓解预测方法
J Clin Rheumatol. 2022 Mar 1;28(2):e334-e339. doi: 10.1097/RHU.0000000000001720.
3
Explainable Deep Learning for Personalized Age Prediction With Brain Morphology.
巨细胞动脉炎诊断与管理的未来:人工智能与预测分析的系统评价
Cureus. 2024 Dec 5;16(12):e75181. doi: 10.7759/cureus.75181. eCollection 2024 Dec.
4
Clinical characteristics and courses of Korean patients with giant cell arteritis: a multi-center retrospective study.韩国巨细胞动脉炎患者的临床特征与病程:一项多中心回顾性研究。
J Rheum Dis. 2024 Jul 1;31(3):160-170. doi: 10.4078/jrd.2024.0007. Epub 2024 May 14.
5
Drug Burden Index Is a Modifiable Predictor of 30-Day Hospitalization in Community-Dwelling Older Adults With Complex Care Needs: Machine Learning Analysis of InterRAI Data.药物负担指数是具有复杂护理需求的社区居住老年人 30 天住院的可修正预测指标:InterRAI 数据分析的机器学习
J Gerontol A Biol Sci Med Sci. 2024 Aug 1;79(8). doi: 10.1093/gerona/glae130.
6
Application of machine learning approaches in predicting clinical outcomes in older adults - a systematic review and meta-analysis.机器学习方法在预测老年人临床结局中的应用 - 系统评价和荟萃分析。
BMC Geriatr. 2023 Sep 14;23(1):561. doi: 10.1186/s12877-023-04246-w.
7
Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task force.评估巨细胞动脉炎的治疗结局和疾病活动变化:一项系统文献回顾,代表巨细胞动脉炎 EULAR-ACR 反应标准工作组为 EULAR-ACR 反应标准的制定提供信息。
RMD Open. 2023 Jun;9(2). doi: 10.1136/rmdopen-2023-003233.
8
Utilization of interpretable machine learning model to forecast the risk of major adverse kidney events in elderly patients in critical care.利用可解释机器学习模型预测重症监护老年患者主要不良肾脏事件的风险。
Ren Fail. 2023 Dec;45(1):2215329. doi: 10.1080/0886022X.2023.2215329.
9
An AI-Powered Clinical Decision Support System to Predict Flares in Rheumatoid Arthritis: A Pilot Study.一种用于预测类风湿关节炎病情发作的人工智能临床决策支持系统:一项初步研究。
Diagnostics (Basel). 2023 Jan 1;13(1):148. doi: 10.3390/diagnostics13010148.
10
Machine learning applied to MRI evaluation for the detection of lymph node metastasis in patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy.机器学习应用于磁共振成像评估,以检测接受新辅助化疗的局部晚期宫颈癌患者的淋巴结转移情况。
Arch Gynecol Obstet. 2023 Jun;307(6):1911-1919. doi: 10.1007/s00404-022-06824-6. Epub 2022 Nov 12.
基于脑形态学的可解释深度学习用于个性化年龄预测
Front Neurosci. 2021 May 28;15:674055. doi: 10.3389/fnins.2021.674055. eCollection 2021.
4
A convolutional neural network with transfer learning for automatic discrimination between low and high-grade synovitis: a pilot study.基于迁移学习的卷积神经网络自动鉴别低级别和高级别滑膜炎:一项初步研究。
Intern Emerg Med. 2021 Sep;16(6):1457-1465. doi: 10.1007/s11739-020-02583-x. Epub 2021 Jan 2.
5
Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study.队列研究衍生的机器学习模型在人类免疫缺陷病毒感染者中对慢性肾脏病的个体预测:一项前瞻性多中心队列研究。
J Infect Dis. 2021 Oct 13;224(7):1198-1208. doi: 10.1093/infdis/jiaa236.
6
2018 Update of the EULAR recommendations for the management of large vessel vasculitis.2018 年版 EULAR 大血管血管炎管理建议更新。
Ann Rheum Dis. 2020 Jan;79(1):19-30. doi: 10.1136/annrheumdis-2019-215672. Epub 2019 Jul 3.
7
Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study.意大利北部经活检证实的巨细胞动脉炎中的病情复发:一项长期随访研究中的特征与预测因素
Medicine (Baltimore). 2016 May;95(19):e3524. doi: 10.1097/MD.0000000000003524.
8
Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study.经活检证实的巨细胞动脉炎复发及治疗结果的预测因素:一项回顾性队列研究。
Rheumatology (Oxford). 2016 Feb;55(2):347-56. doi: 10.1093/rheumatology/kev348. Epub 2015 Sep 18.
9
Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.巨细胞动脉炎患者的疾病复发:一项前瞻性纵向队列研究。
J Rheumatol. 2015 Jul;42(7):1213-7. doi: 10.3899/jrheum.141347. Epub 2015 Apr 15.
10
Youden's index and the weight of evidence.尤登指数与证据权重。
Methods Inf Med. 2015;54(2):198-9. doi: 10.3414/ME14-04-0003. Epub 2015 Feb 6.